Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;4(4):293-7.
doi: 10.1007/s11693-011-9074-7. Epub 2011 Feb 17.

Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting

Affiliations

Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting

Vijaya Gopal et al. Syst Synth Biol. 2010 Dec.

Abstract

Cell-penetrating peptides comprising cloned epitopes that contribute to membrane transduction, DNA-binding and cell targeting functions are known to facilitate nucleic acid delivery. Using the ITASSER software, we predicted the 3-D structure of a well characterized and efficient transfecting cell-penetrating peptide, namely TAT-Mu and its derivative TAT-Mu-AF protein that harbors a targeting ligand, the HER2-binding affibody. Our model predicts TAT-Mu-AF fusion protein as primarily comprising α-helices. The affibody in TAT-Mu-AF is predicted as a 3-helical domain that is distinct from the TAT-Mu domain. Its positioning in three-dimensional structure is oriented in a manner that possibly favors interactions with receptor and facilitates transport to the target site. The linker region between TAT-Mu and the affibody is also predicted as a helix that is likely to stabilize the overall fold of the TAT-Mu-AF complex. Further, the evaluation of secondary structure of the designed TAT-Mu-AF fusion protein by circular dichroism is in support of our predictions.

Keywords: 3-D modelling; Affibody; CPPs; Cell-targeting; Nucleic acid delivery; TAT fusions; iTASSER.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Schematic representation of designed TMAF with cell-targeting ligand (AF) with the vector backbone depicted as thin rectangles. The linker domain depicted in L separates the TAT and Mu domains from the AF domain (Not drawn to scale). b. Pairwise alignment of the amino acid sequences of TM and TMAF using ClustalW program (Thompson et al. 1994). Both TM and TMAF are N-terminal His-tag chimeras followed by a 11-amino acid TAT epitope (YGRKKRRQRRR), 19-amino acid Mu epitope (MRRAHHRRRRASHRRMRG), linker region (TYLSE....NPT) and AF (VDNK......QAPK) followed by the Stop signal. The vector sequences are depicted in thin. Asterisk below the sequence represents identical domains of the designed constructs
Fig. 2
Fig. 2
a Structure of recombinant TMAF protein predicted by I-TASSER program. Models were generated using PyMOL software (DeLano 2002). TAT epitope (red), Mu epitope (blue) and AF (pale cyan). The linker regions (yellow) separate the TAT-Mu domains from the AF. b. CD profile of TMAF protein in the far-UV spectral region (195–250 nm). Mean residue mass ellipticity was obtained using a Jasco J-815 spectropolarimeter (Jasco, MD). Five scans were averaged and the calculated MRE values were plotted as a function of the far-UV-spectrum. The characteristic shape and magnitude of the CD spectral trace is indicative of α-helix conformation

Similar articles

Cited by

References

    1. Abes S, Moulton H, Turner J, Clair P, Richard JP, Iversen P, Gait MJ, Lebleu B. Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem. Soc. Trans. 2007;35:53–55. doi: 10.1042/BST0350053. - DOI - PubMed
    1. Canine BF, Wang Y, Hatefi A. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J Control Release. 2009;138:188–196. doi: 10.1016/j.jconrel.2009.04.017. - DOI - PMC - PubMed
    1. DeLano WL (2002) The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA, USA. http://www.pymol.org
    1. Dilber MS, Phelan A, Aints A, Mohamed AJ, Elliott G, Smith CI, O’Hare P. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 1999;6(1):12–21. doi: 10.1038/sj.gt.3300838. - DOI - PubMed
    1. Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends Pharmacol Sci. 2009;30:341–345. doi: 10.1016/j.tips.2009.04.009. - DOI - PubMed